PROTACs: Targeting breakdown of specific proteins to treat diseases
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Ayush Sinha examines metformin’s role in longevity and reports on the highly-anticipated TAME trial set to further investigate its potential.
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Sophie Beaumont reports on a newly discovered link between Fusobacterium infection and endometriosis.
Sophie Beaumont reports on a new non-hormonal drug for hot flushes, recently approved by the US Food and Drug Administration.
Lola Bell reports on a new study suggesting the size of cancer cells could become a new diagnostic for directing treatment.
Miya McFarlane outlines the findings of a new report from the World Health Organisation suggesting an urgent need for fertility healthcare.
Leah Fogarty reports on a new study that suggests brain waves known as gamma oscillations may be key to treating depression.
Sarya Fidan describes new research from Oxford that reveals the presence of lymphatic vessels in bone, and their role in bone repair.
England is set to eliminate hepatitis C by 2025, making it the first country in the world to do so, thanks to an antiviral drug deal.